Warning: This data is provided for information purpose only. You should not start or stop any medication without consulting your care giver.
Use the Health Monitor application at http://www.healthsupportsystems.com to search for a drug by brand, generic or symptom
HUMIRA
Active Ingredients
ADALIMUMAB
Inctive Ingredients
sodium chloride,monobasic sodium phosphate dihydrate,dibasic sodium phosphate dihydrate,sodium citrate,citric acid monohydrate,mannitol,polysorbate 80,Water,Sodium hydroxide
Usage
HUMIRA is a tumor necrosis factor (TNF) blocker indicated for treatment of:
Rheumatoid Arthritis (RA) (1.1)
Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active disease.
Psoriatic Arthritis (1.2)
Reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage, and improving physical function.
Ankylosing Spondylitis (1.3)
Reducing signs and symptoms in patients with active disease.
Crohn?s Disease (1.4)
Reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn?s disease who have had an inadequate response to conventional therapy. Reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.